Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 10/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 5/20 | 0.32 |
| ▸ | MMP3 | P08254 | 5/20 | 0.32 |
| ▸ | MMP7 | P09237 | 5/20 | 0.32 |
| ▸ | MMP2 | P08253 | 5/20 | 0.32 |
| ▸ | MMP9 | P14780 | 4/20 | 0.32 |
| ▸ | MMP8 | P22894 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8716861 | 0.91 | MMP2 (0.34) | MMP13MEN1KMT2AF10MMP1 | |
| SCHEMBL7303719 | 0.82 | EEF2K (0.36) | MMP13F10MMP1MMP3MMP7 | |
| SCHEMBL7298351 | 0.82 | F2 (0.43) | MMP13F10MMP2MMP9ALDH1A1 | |
| SCHEMBL7295250 | 0.82 | L3MBTL1 (0.39) | MMP13F10MMP1MMP3MMP7 | |
| SCHEMBL7303910 | 0.80 | ACACB (0.43) | F10F2 | |
| SCHEMBL7301032 | 0.80 | TSHR (0.36) | F10GPR119F2 | |
| SCHEMBL7335977 | 0.79 | MMP13 (0.43) | MMP13MMP1MMP3MMP7MMP2 | |
| Acetic Acid SCHEMBL8947584 | 0.78 | F2 (0.44) | ALDH1A1F2 | |
| SCHEMBL27380499 | 0.77 | CYP1A2 (0.31) | F10 | |
| SCHEMBL7296038 | 0.77 | CYP1A2 (0.31) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0559046-B1 | N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors | HOFFMANN LA ROCHE (CH) | 2001-07-11 | — | — | EP | disclosed |
| EP-0559046-A1 | N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1993-09-08 | — | — | EP | disclosed |